As we need the most unity and co-existence as a country, we invite you to come together once again under the roof of our association, which has been joining us for 26 years. We are experiencing the pleasure of implementing the 27th National Congress with the awareness that every brick added onto our solid foundation from the past will enrich us. This year, we will strive to meet the needs of our colleagues’ who are working in different conditions and who have different needs for our constantly growing, developing and renewing branch.We aim to develop our foundation of past years based on 'innovations' added to 'basic information' by making concrete standardization studies, forming flow charts on diagnosis and treatment by closing our lack of knowledge.
For this reason, we have defined our main theme as "algorithms and solutions". We aimed to construct a different program that encourages participation, including a clear flow and tangible gains as well as many innovations to be compatible with our theme at the Congress. We believe that in the areas where we need the most, we will accomplish this with the valuable contributions from internationally respected scholars, as well as our distinguished scientists
In the early spring, we invite you all to a congratulatory congress where we will enjoy the union and coexistence by the beautiful Cesme atmosphere and Aegean trips.
Prof. Dr.Neslihan İnal Emiroğlu
Prof. Dr. Fevziye Toros
Cesar Soutullo completed his residency training in psychiatry and child psychiatry fellowship in University of Cincinnati, Ohio, USA and then he completed PhD program in Psychiatry-Neuroscience, in University of Navarra. Dr. Soutullo is currently director of post graduate training in Child & Adolescent Psychiatry and sub-director, Department of Psychiatry & Medical Psychology, University of Navarra Clinic. Attention Deficit Hyperactivity Disorder is one of the main interests of Cesar Soutello. In addition to clinical experience and many research papers in this subject, he has participated in Conference Organising & Scientific Programme Committe of European Network on Hyperkinetic Disorder (EUNETHYDIS).
Recognition and Prevention (RAP) program, Zucker Hillside Hospital Glen Oaks, New York, USA Christoph Correll, MD, is currently Professor of Psychiatry at Hofstra Northwell School of Medicine, New York, USA and Medical Director of the Recognition and Prevention (RAP) program at the Zucker Hillside Hospital, New York, USA. He completed his medical studies at both the Free University of Berlin in Germany, and at the Dundee University Medical School in Scotland. He is board certified in both general psychiatry and child and adolescent psychiatry, having completed both residencies at The Zucker Hillside Hospital in New York City. Professor Correll’s research and clinical work focus on the identification, characterisation and treatment of adults and youths with severe psychiatric disorders. His areas of expertise include the prodrome, first episode, multi-episode and refractory illness phase of severe psychotic and mood disorders, including schizophrenia, bipolar disorder, major depression, as well as aggressive spectrum disorders. He further focuses on psychopharmacology and comparative effectiveness, the risk–benefit evaluation of psychotropic medications, as well as the extent and mechanisms of cardiometabolic and neuromotor adverse effects. Professor Correll has authored or co-authored over 400 journal articles. He has served on several expert consensus panels on the use of antipsychotics across a range of psychiatric disorders, is a reviewer for over 70 peer-reviewed journals and an editorial board member of 12 scientific journals. Professor Correll is the Principal Investigator or Steering Committee member of several large, federally funded grants. He has received over 30 national and international research awards and fellowships for his work and was listed consecutively for the last 3 years by Thomson Reuters since inception of this metric in 2014 as one of the “most influential scientific minds” and “top 1% cited scientists in the area of psychiatry”.
He completed a combined General and Child & Adolescent Psychiatry residency training at Tel-Aviv University in 1984. Between 1985-1987, he enrolled in a Child & Adolescent Psychiatry clinical research fellowship at Bradley Hospital, Brown University, Providence, RI. Dr. Kaminer was also a visiting fellow at the substance abuse Tx program at Harvard affiliated, McLean Hospital, Belmont, MA. Between 1988-1990, Dr. Kaminer founded and directed the youth substance abuse treatment program at Western Psychiatric Institute & Clinic, Pittsburgh, PA, as an Assistant Professor of Psychiatry. Between 1991-1993, Dr. Kaminer was a Clinical Associate Professor of Psychiatry at the adolescent substance abuse treatment program at Bradley Hospital, and faculty on the Alcohol and Addictions Studies Center, Brown University, Providence, RI. In 1994, Dr. Kaminer was appointed as an Associate Professor at the Department of Psychiatry & The Alcohol Research Center, University of Connecticut Health Center, Farmington, CT. In 2003 he was promoted to a Professor of Psychiatry. Dr. Kaminer has a joint appointment at the Department of Pediatrics, where he is involved in research of youth high-risk driving and suicidal behavior at the Injury Prevention Center of the Connecticut Children’s Medical Center (CCMC), Hartford. Dr. Kaminer main interest has been focusing on clinical research of the assessment, treatment and continuity of care of high-risk behaviors particularly substance use disorders in youth. He has special interest in comorbid depressive disorders and suicidal behavior. Dr. Kaminer has received funding for research from NIAAA, NIDA, CSAT and the Donaghue Foundation in CT. He has been on the editorial board of several peer review journals and served as a guest editor of special issues on adolescent substance abuse including: American Journal of Addictions (2006), Substance Abuse Journal (2008; 2014), and the Child & Adolescent Psyc Clinics of North America (2010). Dr. Kaminer is the coordinator of the Youth Treatment Section of the advisory board of the Research Society on Marijuana (RSMj) and is on the clinical advisory board of Smart Approach to marijuana (SAM). Dr. Kaminer authored/edited 5 books, authored/co-authored more than 150 scientific publications and made numerous scientific and invited presentations nationally and internationally. He also developed several rating scales including: the Teen Addiction Severity Index (T-ASI) that has been translated into several languages including Spanish, Italian, Portuguese, Japanese, Hindu, Dutch, and more, the Teen Treatment Services Review (T-TSR) and the Adolescent Substance Abuse and Goal Commitment questionnaire (ASAGC-Q). Dr. Kaminer and his research team at UConn developed treatment and continued care manuals including the MET and CBT manuals for the Multisite Cannabis Youth Treatment (CYT) study (N=600). Dr. Kaminer most recent books include: 1) Brief Telephone Continuing Care Therapy for Adolescents, Hazelden, (2010); 2) Clinical Manual of Adolescent Substance Abuse Treatment, American Psychiatric Publishing (2011); 3) Youth substance abuse and co-occurring disorders, American Psychiatric Publishing (2016). Dr. Kaminer received his MBA from the University of Hartford in 2000.
is the chief of section on Bipolar Spectrum Disorders, Emotion and Development Branch, NIMH (National Institute of Mental Health). She has been working as clinical professor of psychiatry, Georgetown University School of Medicine. She is one of the leading scientists on affective disorders and neurodevelopmental disorders in children. She has made valuable contributions in defining the symptoms and definition as a subheading in Mood Disorders in DSM 5 of Disruptive Mood Dysregulation Disorder (DMDD). Ellen Leibenluft, is on the editorial board of psychiatric journals with high impact factors, editor of lots of psychiatric books and has written many sections in psychiatric books.
He has lectured widely on various aspects of autism and related disorders. His main area of interest is the diagnosis and treatment of autism and its comorbid conditions. He teaches at the University of Michigan, Ann Arbor, USA, where he is a Professor of Child and Adolescent Psychiatry.
Long Island, New York, 1996 then he completed psychiatry residency and child and adolescent psychiatry fellowship at Stony Brook University in 2000 and 2002 in New York. Current roles and interests: Dr. Pakyurek is a Clinical Professor and the Director of Child and Adolescent Psychiatry Division at UC Davis Medical Center. He is also the medical director for UC Davis Department of Psychiatry Outpatient Clinics and the medical director at The MIND Institute ADHD Clinic. Dr. Pakyurek’s clinical interests are care delivery systems, childhood mood disorders, ADHD, and Autism Spectrum Disorders. He is involved in education and training of medical students and general psychiatry as well as child and adolescent psychiatry residents.
Her clinical interests are Mood disorders and Psychotic disorders in adolescents, Catatonia and Electroconvulsive therapy. She teaches at the University of Michigan, Ann Arbor, USA.
Therapies (CAMHS) for Oxford Health NHS Foundation Trust. He has worked with children and young people for over 30 years since qualifying as a clinical psychologist. Clinically, he works within a specialist child mental health team where he leads a Cognitive Behaviour Therapy (CBT) clinic for children and young people with emotional disorders of anxiety, depression, OCD and PTSD. He is the author of “Think Good Feel Good: A cognitive behaviour therapy workbook for children and young people” and Editor of the book series “Cognitive Behaviour Therapy with children, adolescents and families”. He has contributed to the development of CBT in many countries and has provided workshops for clinicians around the world. He is an active researcher and has published over 150 peer reviewed papers. Recent research projects including large national multi-site randomised controlled trials evaluating the effectiveness of school based CBT programmes on depression (PROMISE) and anxiety (PACES). He is currently researching the use of technology such a computers, telephone apps and messaging to support CBT and in evaluating new models of CBT.